$金斯瑞生物科技(0_老虎社区_美港股上老虎

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":461372,"tweetId":"461372","gmtCreate":1554758393031,"gmtModify":1704797213915,"author":{"id":3435310542032743,"idStr":"3435310542032743","authorId":3435310542032743,"authorIdStr":"3435310542032743","name":"CindyY","avatar":"https://static.tigerbbs.com/4d448dda69a831bbf10db05c4dc47653","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":40,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>$金斯瑞生物科技(01548)$ 和杨森共同研发的第一个CarT疗法在欧洲获得优先药物认定资格，也就是会得到EMA支持，更快审核更快上市。 此疗法为以BCMA为靶点的治疗多发性骨髓瘤的药物。 这是中国首个获得EMA优先药物认定资格的，股价因而大涨。</p></body></html>","htmlText":"<html><head></head><body><p>$金斯瑞生物科技(01548)$ 和杨森共同研发的第一个CarT疗法在欧洲获得优先药物认定资格，也就是会得到EMA支持，更快审核更快上市。 此疗法为以BCMA为靶点的治疗多发性骨髓瘤的药物。 这是中国首个获得EMA优先药物认定资格的，股价因而大涨。</p></body></html>","text":"$金斯瑞生物科技(01548)$ 和杨森共同研发的第一个CarT疗法在欧洲获得优先药物认定资格，也就是会得到EMA支持，更快审核更快上市。 此疗法为以BCMA为靶点的治疗多发性骨髓瘤的药物。 这是中国首个获得EMA优先药物认定资格的，股价因而大涨。","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/461372","repostId":0,"isVote":1,"tweetType":1,"viewCount":3190,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["01548"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":213,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":1468601,"commentId":"1468601","gmtCreate":1554880953115,"gmtModify":1554880953115,"authorId":3453264688370209,"author":{"id":3453264688370209,"idStr":"3453264688370209","authorId":3453264688370209,"name":"八十一度仙","avatar":"https://static.tigerbbs.com/5c75c9c099f6ee06296b9aa59b0ddbff","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":461372,"objectIdStr":"461372","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"难怪","text":"难怪","html":"难怪","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}

评论（1）

热议股票